Market Closed -
TEL AVIV STOCK EXCHANGE
07:24:09 2024-04-25 am EDT
|
5-day change
|
1st Jan Change
|
1,938
ILa
|
-2.42%
|
|
+0.31%
|
-12.98%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
960.1
|
924.6
|
920.4
|
615
|
1,280
|
1,114
|
-
|
-
|
Enterprise Value (EV)
1 |
960.1
|
924.6
|
920.4
|
615
|
1,280
|
1,114
|
1,114
|
1,114
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.2
x
|
2.13
x
|
2.7
x
|
1.31
x
|
2.51
x
|
1.94
x
|
1.58
x
|
1.41
x
|
EV / Revenue
|
2.2
x
|
2.13
x
|
2.7
x
|
1.31
x
|
2.51
x
|
1.94
x
|
1.58
x
|
1.41
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
14,821,198
x
|
-
|
-
|
-
|
EV / FCF
|
11.5
x
|
22.5
x
|
-22.1
x
|
-
|
-233
x
|
17.4
x
|
8.43
x
|
7.16
x
|
FCF Yield
|
8.72%
|
4.44%
|
-4.52%
|
-
|
-0.43%
|
5.75%
|
11.9%
|
14%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
40,512
|
44,731
|
44,786
|
44,826
|
57,476
|
57,480
|
-
|
-
|
Reference price
2 |
23.70
|
20.67
|
20.55
|
13.72
|
22.27
|
19.38
|
19.38
|
19.38
|
Announcement Date
|
2/12/20
|
2/10/21
|
3/15/22
|
3/15/23
|
3/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
436.2
|
433.1
|
340.3
|
469.1
|
510.9
|
573.4
|
706
|
787.8
|
EBITDA
|
-
|
-
|
-
|
-
|
86.36
|
-
|
-
|
-
|
EBIT
1 |
78.14
|
62.53
|
-2.286
|
16.44
|
36.08
|
56.88
|
103.2
|
124.7
|
Operating Margin
|
17.91%
|
14.44%
|
-0.67%
|
3.5%
|
7.06%
|
9.92%
|
14.62%
|
15.83%
|
Earnings before Tax (EBT)
1 |
78.81
|
60.35
|
-6.19
|
-8.192
|
30.22
|
53.82
|
99.74
|
120.8
|
Net income
1 |
76.31
|
55.72
|
-7.323
|
-8.417
|
29.7
|
46.19
|
84
|
102.4
|
Net margin
|
17.49%
|
12.86%
|
-2.15%
|
-1.79%
|
5.81%
|
8.06%
|
11.9%
|
13%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
83.7
|
41.06
|
-41.62
|
-
|
-5.499
|
64.02
|
132.1
|
155.6
|
FCF margin
|
19.19%
|
9.48%
|
-12.23%
|
-
|
-1.08%
|
11.17%
|
18.71%
|
19.75%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
109.69%
|
73.69%
|
-
|
-
|
-
|
138.6%
|
157.28%
|
151.92%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/12/20
|
2/10/21
|
3/15/22
|
3/15/23
|
3/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
71.3
|
103.3
|
95.31
|
76.9
|
111.8
|
164.8
|
113.6
|
140.1
|
146.1
|
130.6
|
137.8
|
142.7
|
145.7
|
147.2
|
EBITDA
|
1.764
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-2.489
|
-10.84
|
0.8346
|
-7.478
|
8.893
|
14.57
|
1.069
|
9.846
|
16.82
|
9.951
|
14.74
|
15.35
|
15.13
|
12.04
|
Operating Margin
|
-3.49%
|
-10.49%
|
0.88%
|
-9.72%
|
7.95%
|
8.84%
|
0.94%
|
7.03%
|
11.51%
|
7.62%
|
10.7%
|
10.76%
|
10.38%
|
8.18%
|
Earnings before Tax (EBT)
1 |
-2.616
|
-15.32
|
-6.063
|
-12.75
|
1.715
|
10.68
|
-6.641
|
7.129
|
12.69
|
18.01
|
14.01
|
14.61
|
14.36
|
11.28
|
Net income
1 |
-2.616
|
-16.45
|
-6.202
|
-12.78
|
1.68
|
10.68
|
-6.689
|
6.781
|
12.41
|
18.13
|
12.04
|
12.52
|
12.26
|
9.553
|
Net margin
|
-3.67%
|
-15.92%
|
-6.51%
|
-16.62%
|
1.5%
|
6.48%
|
-5.89%
|
4.84%
|
8.5%
|
13.88%
|
8.74%
|
8.77%
|
8.42%
|
6.49%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/22/21
|
3/15/22
|
5/17/22
|
8/17/22
|
11/22/22
|
3/15/23
|
5/24/23
|
8/16/23
|
11/13/23
|
3/6/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
83.7
|
41.1
|
-41.6
|
-
|
-5.5
|
64
|
132
|
156
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
7.89
|
17.9
|
12.2
|
13.7
|
21
|
1.74
|
1.39
|
1.11
|
Capex / Sales
|
1.81%
|
4.12%
|
3.59%
|
2.93%
|
4.1%
|
0.3%
|
0.2%
|
0.14%
|
Announcement Date
|
2/12/20
|
2/10/21
|
3/15/22
|
3/15/23
|
3/6/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -12.98% | 292M | | -4.06% | 86.13B | | +1.97% | 39.82B | | +56.59% | 25.23B | | -14.82% | 15.36B | | -8.82% | 11.95B | | -16.29% | 11.6B | | -41.58% | 11.51B | | +6.14% | 8.71B | | -7.02% | 8.12B |
Biopharmaceuticals
|